
Adtalem Global Education Inc. (NYSE:CVSA – Free Report) – Equities researchers at Zacks Research lowered their Q2 2027 EPS estimates for shares of Adtalem Global Education in a report issued on Friday, November 13th. Zacks Research analyst Team now expects that the company will earn $2.11 per share for the quarter, down from their prior estimate of $2.38. The consensus estimate for Adtalem Global Education’s current full-year earnings is $9.08 per share. Zacks Research also issued estimates for Adtalem Global Education’s Q4 2027 earnings at $2.38 EPS, FY2027 earnings at $9.04 EPS, Q1 2028 earnings at $2.35 EPS, Q2 2028 earnings at $2.42 EPS, Q3 2028 earnings at $2.57 EPS, Q4 2028 earnings at $2.68 EPS, FY2028 earnings at $10.01 EPS, Q1 2029 earnings at $2.66 EPS and FY2029 earnings at $11.61 EPS.
Other equities analysts have also issued research reports about the company. Weiss Ratings upgraded Adtalem Global Education from a “hold (c)” rating to a “hold (c+)” rating in a research note on Wednesday, October 21st. Wall Street Zen raised Adtalem Global Education from a “hold” rating to a “buy” rating in a research report on Sunday, September 27th. Truist Financial downgraded Adtalem Global Education from a “buy” rating to a “hold” rating and set a $140.00 price target on the stock. in a research note on Thursday, September 3rd. Finally, BMO Capital Markets cut their price objective on Adtalem Global Education from $148.00 to $145.00 and set an “outperform” rating on the stock in a report on Monday, October 5th. Two analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, Adtalem Global Education has a consensus rating of “Hold” and a consensus price target of $151.67.
Check Out Our Latest Stock Report on Adtalem Global Education
Adtalem Global Education Price Performance
Shares of CVSA opened at $116.92 on Monday. The firm has a market capitalization of $3.89 billion, a PE ratio of 13.55, a price-to-earnings-growth ratio of 0.86 and a beta of 0.70. The company has a debt-to-equity ratio of 0.35, a current ratio of 0.81 and a quick ratio of 0.81. Adtalem Global Education has a 1-year low of $86.97 and a 1-year high of $142.13. The company’s fifty day moving average price is $124.36 and its 200-day moving average price is $121.80.
Adtalem Global Education (NYSE:CVSA – Get Free Report) last posted its quarterly earnings results on Thursday, October 29th. The company reported $2.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.90 by $0.29. Adtalem Global Education had a net margin of 12.84% and a return on equity of 21.79%. The business had revenue of $511.53 million during the quarter.
Institutional Inflows and Outflows
An institutional investor recently raised its position in Adtalem Global Education stock. Kendall Capital Management raised its holdings in Adtalem Global Education Inc. (NYSE:CVSA – Free Report) by 23.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 14,375 shares of the company’s stock after purchasing an additional 2,753 shares during the quarter. Kendall Capital Management’s holdings in Adtalem Global Education were worth $1,757,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 98.84% of the company’s stock.
Insider Buying and Selling
In other news, CAO Manjunath Gangadharan sold 1,802 shares of the company’s stock in a transaction on Thursday, August 27th. The shares were sold at an average price of $137.18, for a total value of $247,198.36. Following the sale, the chief accounting officer directly owned 5,083 shares of the company’s stock, valued at $697,285.94. This represents a 26.17% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Stephen W. Beard sold 4,667 shares of the company’s stock in a transaction on Friday, October 9th. The shares were sold at an average price of $130.77, for a total transaction of $610,303.59. Following the completion of the sale, the chief executive officer directly owned 469,158 shares in the company, valued at $61,351,791.66. This trade represents a 0.98% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 10,108 shares of company stock valued at $1,331,918 over the last three months. 2.70% of the stock is currently owned by insiders.
Adtalem Global Education Company Profile
Adtalem Global Education is a U.S.-based education company focused primarily on healthcare and professional education. Its institutions offer undergraduate and graduate degree programs, professional training, and online learning for students preparing for careers in fields such as nursing, medicine, veterinary medicine, and business. Its institutions include Chamberlain University, Walden University, the American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine.
Read More
- Five stocks we like better than Adtalem Global Education
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Receive News & Ratings for Adtalem Global Education Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adtalem Global Education and related companies with MarketBeat.com's FREE daily email newsletter.
